Patents by Inventor Olivier Colliou

Olivier Colliou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230147605
    Abstract: An unobtrusive ambulatory wearable biosensor device, system, and method continuously monitors blood oxygen saturation of a patient in their free-living conditions. The wearable biosensor system may include a finger sensor device, wrist module device, relay device, and wearable sensor patch.
    Type: Application
    Filed: November 5, 2021
    Publication date: May 11, 2023
    Inventors: Nersi Nazari, Olivier Colliou, Wenkang Qi
  • Publication number: 20220323364
    Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
    Type: Application
    Filed: May 10, 2022
    Publication date: October 13, 2022
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
  • Patent number: 11357730
    Abstract: Apparatuses for use with a pharmaceutically acceptable carrier. The apparatus can include a partial power source, which in turn includes electrodes or materials that are configured to generate an electrical potential upon contacting or being exposed to an ionic solution. The apparatus can further include a circuit electrically or communicatively coupled to the partial power source. The circuit can generate various types of signals, such as RF signals, when powered by the partial power source. The circuit is stably fittable to the pharmaceutically acceptable carrier. The apparatus can further include a barrier, a protective layer, or a membrane that isolates the electrodes or materials from the ionic solution and is configured to be dissolved by the ionic solution.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: June 14, 2022
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
  • Patent number: 11185287
    Abstract: A device-securing overlay includes a wearable strip that has a controlled applicant to fit over at least a portion of a wearable device, while an adhesive on an under portion of the wearable strip is placed in contact with at least a top portion of an outer rim of the wearable device as well as a surface upon which the wearable device is placed, without covering portions of the wearable device that require ventilation or an unobstructed view.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: November 30, 2021
    Assignee: Vital Connect, Inc.
    Inventors: Olivier Colliou, Rod Moghadam
  • Patent number: 10856741
    Abstract: A system and method for detecting and monitoring core body temperature are disclosed. The system includes a patch device and an electronic module coupled to the patch device. The method includes providing a patch device, coupling an electronic module to the patch device to provide a wearable device, and monitoring core body temperature of a user using the wearable device.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: December 8, 2020
    Assignee: Vital Connect, Inc.
    Inventors: Dhwanil Damania, Olivier Colliou, Arshan Aga
  • Patent number: 10517506
    Abstract: Low profile antennas for ingestible devices, such as ingestible event markers, are provided. Aspects of the ingestible devices of the invention include low profile signal transmission antennas configured such that they are flexible or degrade after use, allowing the antenna and attached components to pass easily through the body. Embodiments of the low profile antennas are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: December 31, 2019
    Assignee: Proteus Digital Health, Inc.
    Inventors: Timothy L. Robertson, Olivier Colliou, Eric J. Snyder, Mark Zdeblick
  • Publication number: 20190388030
    Abstract: A device-securing overlay includes a wearable strip that has a controlled applicant to fit over at least a portion of a wearable device, while an adhesive on an under portion of the wearable strip is placed in contact with at least a top portion of an outer rim of the wearable device as well as a surface upon which the wearable device is placed, without covering portions of the wearable device that require ventilation or an unobstructed view.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 26, 2019
    Inventors: Olivier Colliou, Rod Moghadam
  • Publication number: 20190261888
    Abstract: A re-wearable wireless device configured to be attached to a user is disclosed. In some embodiments, the re-wearable wireless device includes a disposable component and a reusable component. The disposable component may include a first electrode, a second electrode, a cradle, and a battery. The cradle may include a first electrical connector, wherein the first electrical connector is electrically coupled to the first electrode, the second electrode, and the battery. The reusable component may include an electronics module, a housing configured to latch into the cradle, a second electrical connector, wherein the second electrical connector electrically couples the reusable component to the first electrode, the second electrode, and the battery. The re-wearable wireless device may be configured to detect a conductive electrical signal through the first electrode and the second electrode.
    Type: Application
    Filed: May 7, 2019
    Publication date: August 29, 2019
    Inventors: Mark Zdeblick, Kien Lam, Jeremy Frank, Robert Azevedo, Elizabeth Klein, David O'Reilly, Aditya Dua, Joan Hain, Robert Leichner, Christopher Reggiardo, Lawrence Arne, Arna Ionescu Stoll, Kristin Pollock, Olivier Colliou, James Fish
  • Publication number: 20190133958
    Abstract: Apparatuses for use with a pharmaceutically acceptable carrier. The apparatus can include a partial power source, which in turn includes electrodes or materials that are configured to generate an electrical potential upon contacting or being exposed to an ionic solution. The apparatus can further include a circuit electrically or communicatively coupled to the partial power source. The circuit can generate various types of signals, such as RF signals, when powered by the partial power source. The circuit is stably fittable to the pharmaceutically acceptable carrier. The apparatus can further include a barrier, a protective layer, or a membrane that isolates the electrodes or materials from the ionic solution and is configured to be dissolved by the ionic solution.
    Type: Application
    Filed: December 28, 2018
    Publication date: May 9, 2019
    Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
  • Patent number: 10238604
    Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: March 26, 2019
    Assignee: Proteus Digital Health, Inc.
    Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
  • Publication number: 20180160909
    Abstract: A system and method for detecting and monitoring core body temperature are disclosed. The system includes a patch device and an electronic module coupled to the patch device. The method includes providing a patch device, coupling an electronic module to the patch device to provide a wearable device, and monitoring core body temperature of a user using the wearable device.
    Type: Application
    Filed: December 14, 2016
    Publication date: June 14, 2018
    Inventors: Dhwanil Damania, Olivier Colliou, Arshan Aga
  • Patent number: 9439599
    Abstract: A body associated device comprises a housing, an adhesive layer configured to be applied to a body of a living subject, and at least one standoff located between the housing and the adhesive layer. An electronic module may be located within the housing of the body associated device. A personal communication system comprises a body associated device including an electronic module and further comprises a feedback portion coupled to the housing and to the electronic module. The feedback portion is configured to communicate information between the living subject and the body associated device. An external local node is operative to provide at least one of transmit communications to and receive communications from the body associated device.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: September 13, 2016
    Assignee: Proteus Digital Health, Inc.
    Inventors: Todd Thompson, Olivier Colliou, Robert Duck, Yashar Behzadi
  • Publication number: 20150182463
    Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
    Type: Application
    Filed: December 15, 2014
    Publication date: July 2, 2015
    Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
  • Patent number: 8945005
    Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: February 3, 2015
    Assignee: Proteus Digital Health, Inc.
    Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
  • Patent number: 8932221
    Abstract: Multi-directional transmitters for in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body multi-direction transmitters of the invention include signal transmitters configured to transmit an identifying signal in at least two different directions in an x-y plane. Embodiments of the in-body devices are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: January 13, 2015
    Assignee: Proteus Digital Health, Inc.
    Inventors: Olivier Colliou, Timothy Robertson, Mark Zdeblick
  • Publication number: 20140206976
    Abstract: A body associated device comprises a housing, an adhesive layer configured to be applied to a body of a living subject, and at least one standoff located between the housing and the adhesive layer. An electronic module may be located within the housing of the body associated device. A personal communication system comprises a body associated device including an electronic module and further comprises a feedback portion coupled to the housing and to the electronic module. The feedback portion is configured to communicate information between the living subject and the body associated device. An external local node is operative to provide at least one of transmit communications to and receive communications from the body associated device.
    Type: Application
    Filed: March 8, 2012
    Publication date: July 24, 2014
    Applicant: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Todd Thompson, Olivier Colliou, Robert Duck, Yashar Behzadi
  • Publication number: 20140180202
    Abstract: An ingestible therapy activator system and method are provided. In one aspect, the ingestible therapy activator includes an ingestible device having an effector module to send an effector instruction and a responder module associated with a therapeutic device. The responder module may receive and process the effector instruction, resulting in a response by the therapeutic device. Examples of responses by therapeutic device include activating a therapy, deactivating a therapy, modulating a therapy, and discontinuing a therapy.
    Type: Application
    Filed: February 26, 2014
    Publication date: June 26, 2014
    Applicant: Proteus Digital Health, Inc.
    Inventors: MARK ZDEBLICK, MARC JENSEN, OLIVIER COLLIOU, ANGELA STRAND
  • Patent number: 8738154
    Abstract: Implantable stimulation devices are provided. Aspects of the devices include a multiplexed multi-electrode component configured for neural stimulation. The multiplexed multi-electrode component includes two or more individually addressable satellite electrode structures electrically coupled to a common conductor. The satellite structures include a hermetically sealed integrated circuit controller operatively coupled to one or more electrodes. Also provided are systems that include the devices of the invention, as well as methods of using the systems and devices in a variety of different applications.
    Type: Grant
    Filed: May 24, 2011
    Date of Patent: May 27, 2014
    Assignee: Proteus Digital Health, Inc.
    Inventors: Mark Zdeblick, Todd Thompson, Marc Jensen, Olivier Colliou, Angela Strand
  • Patent number: 8583227
    Abstract: Portable electroviscerography systems are provided. Aspects of the systems include a body-associated receiver and an ingestible identifier unit, both of which are configured to detect visceral electrical signals. The system communicates with an extra-corporeal data processor configured to receive data from the body-associated receiver and generate and electroviscerogram from the received data. Also provided are methods of producing electroviscerograms using systems of the present invention.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: November 12, 2013
    Assignee: Proteus Digital Health, Inc.
    Inventors: George Savage, Hooman Hafezi, Olivier Colliou, Mark Zdeblick, Angela Strand
  • Patent number: 8540632
    Abstract: Low profile antennas for ingestible devices, such as ingestible event markers, are provided. Aspects of the ingestible devices of the invention include low profile signal transmission antennas configured such that they are flexible or degrade after use, allowing the antenna and attached components to pass easily through the body. Embodiments of the low profile antennas are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: September 24, 2013
    Assignee: Proteus Digital Health, Inc.
    Inventors: Timothy L. Robertson, Olivier Colliou, Eric Snyder, Mark J. Zdeblick